American Society of Hirudotherapy

HIRUDOTHERAPY IN RECONSTRUCTIVE SURGERY: CASE-REPORTS AND REVIEW

Heinz P, Tvrdý P, Pink R, Dvořák Z, Michl P (2020) · Acta Chirurgiae Plasticae

Expert opinion / guidance: FDA has cleared Hirudo medicinalis as a medical device (K040187, June 21 2004) for venous congestion in surgical flaps. Other uses are off-label or investigational.Study record: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.

Study Profile

Type
Czech narrative review with embedded clinical case reports on hirudotherapy (Hirudo medicinalis, Hirudo verbana) for venous congestion in reconstructive surgery contexts including digit/auricle/lip replantation and head-and-neck flaps (Czech Republic)
Scope
Discussion of leech application in critical post-operative periods when microcirculation/venous drainage is impaired and venostasis threatens tissue survival; case-illustrated indications include digit, auricle, lip, and nasal-tip replantations as well as head-and-neck reconstructive flaps

Key Findings

  • Czech-language reconstructive-surgery review documenting the modern indications for hirudotherapy in central European practice
  • Reaffirms the Derganc and Zdravic 1960 priority on flap-congestion leech application
  • Identifies the 'critical post-operative period' as the principal window for leech rescue when venous drainage is inadequate
  • Catalogs the standard indications: digit, auricle, lip, and nasal-tip replantation plus head-and-neck reconstructive flaps
  • Documents that European reconstructive surgeons widely recognize leeches as a legitimate venous-drainage rescue tool

Limitations

  • Narrative review without systematic methodology or quantitative synthesis
  • Case reports embedded for illustration rather than systematic outcome analysis
  • Czech-language original limits global accessibility
  • No new primary data - relies on prior published case series and RCTs
  • Does not provide GRADE-style certainty assessment

Clinical Implications

Heinz 2020 provides a useful European narrative review documenting that hirudotherapy is a standard part of reconstructive surgery practice in central Europe for venous congestion across multiple flap and replantation contexts. For US clinicians, the review reinforces the K040187-cleared indication and supports inclusion of leech therapy in microsurgical flap-salvage protocols. The trial is cited here as contextual European-practice evidence rather than as a primary outcome study. The Czech perspective adds geographic diversity to the predominantly German and Anglophone reconstructive-surgery hirudotherapy literature.

Related studies

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.